GPS1 and breast carcinoma: In addition, the analysis of the effect of GPS1 methylation status on the prognosis of breast cancer revealed that the hypomethylation status of the five methylation sites may be an important factor affecting the prognosis, and it can be used as an effective biomarker to identify the poor prognosis of breast cancer.